A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7076 (2006.01) A61K 31/18 (2006.01) A61K 31/4015 (2006.01) A61K 31/44 (2006.01) A61K 31/444 (2006.01) A61K 31/4709 (2006.01) A61K 31/472 (2006.01) A61K 31/50 (2006.01) A61K 31/519 (2006.01) A61P 11/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2694987
The invention features compositions and methods employing combinations of an A2A receptor agonist and a PDE inhibitor for the treatment of a B-cell proliferative disorder, e g, multiple myeloma In at least one embodiment, the compositions of the invention comprise a PDE inhibitor active against at least two of PDE 2, 3,4, and 7 In at least one embodiment, the compositions of the invention compnse further administenng an antiproliferative compound.
L'invention concerne des compositions et des procédés employant des combinaisons d'un agoniste du récepteur A2A et d'un inhibiteur PDE dans le traitement d'un trouble prolifératif de lymphocytes B, comme par exemple un myélome multiple. Dans au moins une forme de réalisation de l'invention, les compositions de l'invention comprennent un inhibiteur PDE actif contre au moins deux des PDE 2, 3, 4 et 7. Dans au moins une forme de réalisation, les compositions de l'invention compensent l'administration en plus d'un composé antiprolifératif.
Lee Margaret S.
Pierce Laura
Rickles Richard
Combinatorx Incorporated
Gowling Lafleur Henderson Llp
Zalicus Inc.
LandOfFree
Combinations for the treatment of b-cell proliferative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations for the treatment of b-cell proliferative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations for the treatment of b-cell proliferative... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1495429